+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bone Growth Stimulators - Global Market Trajectory & Analytics

  • ID: 5139567
  • Report
  • February 2022
  • Region: Global
  • 492 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes Companies
  • Elizur Corporation
  • Medtronic plc
  • Ossatec Benelux B.V.

Global Bone Growth Stimulators Market to Reach $1.27 Billion by 2026


Bone growth stimulation represents a therapy that aids bone healing following a fracture and spinal fusion surgical process. Growth in the market is facilitated by factors such as aging population, increasing cases of orthopedic conditions such as osteoporosis, degenerative joint disorders, and preference for minimally or non-invasive surgeries. Rising incidence of orthopedic disorders coupled with high uptake of the therapy in healthcare facilities also ensure steady growth opportunities in the market. The market growth is anticipated to be also favored by increasing cases of accidents and trauma. Road accidents along with trauma hold the risk of causing serious spinal injuries and delayed union and non-union fractures, requiring people to undergo surgeries. Bone growth stimulators promote bone healing during treatments for union and non-union fractures, fresh fractures and failed spinal fusions by applying electrical current or ultrasonic waves to the fusion site. Rising incident of vertebral fracture and associated complications is also expected to drive demand for bone growth stimulators. These devices are anticipated to be extensively used to treat delayed union & non-union bone fractures, which account for significant share of the market.

Amid the COVID-19 crisis, the global market for Bone Growth Stimulators estimated at US$999.4 Million in the year 2020, is projected to reach a revised size of US$1.27 Billion by 2026, growing at a CAGR of 4.2% over the analysis period. Stimulation Devices, one of the segments analyzed in the report, is projected to grow at a 4.3% CAGR to reach US$739 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bone Morphogenetic Proteins (BMP) segment is readjusted to a revised 3.8% CAGR for the next 7-year period. This segment currently accounts for a 35.1% share of the global Bone Growth Stimulators market. Bone growth stimulation devices comprise external bone growth stimulators, implanted bone growth stimulators, and Ultrasonic bone growth stimulators. External bone growth stimulators represent portable devices intended to be worn by a patient on the skin using straps for securing them. Ultrasound bone growth stimulators is a noninvasive intervention, designed to transmit low-density, pulsed, high-frequency acoustic pressure waves to improve healing of fresh fractures and promote healing of delayed unions and non-unions.



The U.S. Market is Estimated at $527.7 Million in 2021, While China is Forecast to Reach $83.9 Million by 2026


The Bone Growth Stimulators market in the U.S. is estimated at US$527.7 Million in the year 2021. The country currently accounts for a 51.34% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$83.9 Million in the year 2026 trailing a CAGR of 6.1% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR while Rest of European market (as defined in the study) will reach US$89.5 Million by the end of the analysis period. The US dominates market growth in the North America region, given the rising demand of the treatment for spinal fusion and fracture cases and increasing awareness regarding PEMF-based external devices. The regional market holds the leading share due to supportive reimbursement policies, technological advances and the presence of major orthopedic device makers. Future growth of the US bone growth stimulators market is likely to be propelled by increasing adoption of these devices coupled with rising number of US FDA approvals in the recent years. Growth in the Asia-Pacific region is being driven by increasing incidence of orthopedic disorders and rising adoption of non-invasive therapies for bone growth stimulation.

Platelet-Rich Plasma (PRP) Segment to Reach $129.7 Million by 2026


Platelet-rich plasma (PRP) is a concentrate of platelet-rich plasma protein extracted from whole blood, centrifuged to eliminate red blood cells. The idea of platelet rich plasma is intended to help patients in enhancing the healing process. Surgeons using the approach focus on a specific part of a patient`s blood sample that is placed on the surgical site for expediting bone healing. In the global Platelet-Rich Plasma (PRP) segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$81.2 Million in the year 2020 will reach a projected size of US$111.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.5 Million by the year 2026, while Latin America will expand at a 6% CAGR through the analysis period.

Select Competitors (Total 62 Featured) -

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes Companies
  • Elizur Corporation
  • Medtronic plc
  • Orthofix International N.V
  • Ossatec Benelux B.V.
  • Stryker Corporation
  • Synergy Orthopedics
  • Terumo Corporation
  • Zimmer Biomet Holdings Inc.
Frequently Asked Questions about the Global Market for Bone Growth Stimulators

What is the estimated value of the Global Market for Bone Growth Stimulators?

The Global Market for Bone Growth Stimulators was estimated to be valued at $999.4 Million in 2020.

What is the growth rate of the Global Market for Bone Growth Stimulators?

The growth rate of the Global Market for Bone Growth Stimulators is 4.1%, with an estimated value of $1270.0 Million by 2026.

What is the forecasted size of the Global Market for Bone Growth Stimulators?

The Global Market for Bone Growth Stimulators is estimated to be worth $1270.0 Million by 2026.

Who are the key companies in the Global Market for Bone Growth Stimulators?

Key companies in the Global Market for Bone Growth Stimulators include Arthrex, Inc., Bioventus LLC, DePuy Synthes Companies, Elizur Corporation, Medtronic plc, Orthofix International N.V, Ossatec Benelux B.V., Stryker Corporation and Terumo Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes Companies
  • Elizur Corporation
  • Medtronic plc
  • Ossatec Benelux B.V.

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Bone Growth Stimulators - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020,2021, & 2022
  • COVID-19 Casts Shadow over Normalcy of Orthopedic Surgery Volumes
  • Number of Elective Orthopaedic Surgical Procedures Conducted in the US: April-June 2020 Vs April-June 2019
  • Pandemic Scare Helps Hospitals Shift Gears from In-patient to Out-patient Surgeries
  • Bone Growth Stimulator: A Prelude
  • Types of Bone Growth Stimulators
  • Market Overview and Outlook
  • Hospitals & Clinics: Primary End-User Segment
  • US Holds Predominance in Global Bone Growth Stimulators Market
  • US FDA Proposes Down-Classification of Non-Invasive Bone Growth Stimulators
  • Competition
  • Market Share of Leading Players in Global Bone Growth Stimulators Market: 2019
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Increase in Number of Fractures and Rise in incidence of Delayed Union & Nonunion Bone Fractures Elevates Demand for Bone Stimulators
  • Osteoporosis and Other Bone Related Health Concerns: Factsheet
  • Hip Fracture Stats
  • Select Musculoskeletal Conditions - Percentage Breakdown by Age Group
  • Percentage Share Breakdown of Number of Fractures by Age Group: 2019
  • Rise in Vertebral Fractures to Steer Growth
  • Vertebral Fracture Stats
  • Increasing Cases of Trauma Underpins Demand
  • Rise in Incidence Osteoporosis to Benefit Market Growth
  • Global Osteoporosis Prevalence: Number of People with Osteoporosis in Millions by Select Country/Region for 2012 and 2022P
  • % of Women Affected by Osteoporosis
  • Spinal Fusion Surgery Holds Strong Opportunities
  • US Spinal Fusion Surgery Market: Percentage Breakdown of Procedure Volume by Age Group
  • Bone Stimulators Display Potential for Application in Treatment of Osteoarthritis
  • Role of Platelet-Rich Plasma (PRP) as Bone Growth Stimulants
  • Rise in Minimally Invasive Surgeries and Robotic Surgeries to Boost Prospects
  • World Surgical Robots Market by Surgery Type: 2019
  • Technology Advancements in Implants Drive Surgery Volumes, Supporting the demand for Bone Stimulators
  • Demographic Factors Buoying Growth
  • Epidemic Proportion of Obesity
  • Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
  • Average Per Capita Annual Health Expenditure (In US$) due to Obesity
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Alarming Levels of Diabetes Incidence and Increased Risk of Impaired Fracture Healing to Benefit Demand
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • World Diabetes Prevalence (2000-2045P)
  • Aging Population and their Vulnerability to Various Bone and Joint Related Diseases and Disorders Drive Healthy Market Growth
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Rise in Healthcare Expenditure to Drive Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Bone Growth Stimulators Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 62
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes Companies
  • Elizur Corporation
  • Medtronic plc
  • Orthofix International N.V
  • Ossatec Benelux B.V.
  • Stryker Corporation
  • Synergy Orthopedics
  • Terumo Corporation
  • Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown